Event Type
Disclosure
Voluntary
Variant
8-K
Other Events. Alzamend Neuro , Inc., a Delaware corporation (the “ Company ”) has learned that Andrew H. Woo, M.D., Ph.D., a director of the Company, passed awa
Financial Statements And Exhibits (d) Exhibits: Exhibit No. Description 101 Pursuant to Rule 406 of Regulation S-T, the cover page is formatted in Inline XBRL (